Diethyl-Lodoxamide is a potent agonist of the GPR35 receptor, demonstrating significant potential for the treatment of inflammatory bowel disease. It activates GPR35 in human, mouse, and rat models, exhibiting similar EC50 values across these species. Notably, Diethyl-Lodoxamide has been shown to alleviate clinical symptoms in DSS-induced mouse models of inflammatory bowel disease, offering a more effective solution compared to traditional therapies such as 5-ASA. The compound's pharmaceutical properties have been carefully optimized to align with advanced drug design requirements.
Diethyl-Lodoxamide is a potent agonist of the GPR35 receptor, demonstrating significant potential for the treatment of inflammatory bowel disease. It activates GPR35 in human, mouse, and rat models, exhibiting similar EC50 values across these species. Notably, Diethyl-Lodoxamide has been shown to alleviate clinical symptoms in DSS-induced mouse models of inflammatory bowel disease, offering a more effective solution compared to traditional therapies such as 5-ASA. The compound's pharmaceutical properties have been carefully optimized to align with advanced drug design requirements.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
